Eltirads Framework for Thyroid Nodule Classification Integrating Elastography, Tirads, and Radiomics With Interpretable Machine Learning Publisher Pubmed

Summary: Can AI improve thyroid diagnosis? Study finds ELTIRADS with SVM achieves 92% accuracy. #ThyroidCancer #MachineLearning

Barzegargolmoghani E¹ ; Mohebi M^{1, 9} ; Gohari Z² ; Aram S¹ ; Mohammadzadeh A⁵ ; Firouznia S⁶ ; Shakiba M³ ; Naghibi H³ ; Moradian S⁷ ; Ahmadi M¹ ; Almasi K¹ ; Issaiy M³ ; Anjomrooz M² ; Tavangar SM⁴ Show All Authors
Source: Scientific Reports Published:2025

Abstract

Early detection of malignant thyroid nodules is crucial for effective treatment, but traditional diagnostic methods face challenges such as variability in expert opinions and limited integration of advanced imaging techniques. This prospective cohort study investigates a novel multimodal approach, integrating traditional methods with advanced machine learning techniques. We studied 181 patients who underwent fine-needle aspiration (FNA) biopsy, each contributing one nodule, resulting in a total of 181 nodules for our analysis. Data collection included sex, age, and ultrasound imaging, which incorporated elastography. Features extracted from these images included Thyroid Imaging Reporting and Data System (TIRADS) scores, elastography parameters, and radiomic features. The pathological results based on the FNA biopsy, provided by the pathologists, served as our gold standard for nodule classification. Our methodology, termed ELTIRADS, combines these features with interpretable machine learning techniques. Performance evaluation showed that a Support Vector Machine (SVM) classifier using TIRADS, elastography data, and radiomic features achieved high accuracy (0.92), with sensitivity (0.89), specificity (0.94), precision (0.89), and F1 score (0.89). To enhance interpretability, we used hierarchical clustering, shapley additive explanations (SHAP), and partial dependence plots (PDP). This combined approach holds promise for enhancing the accuracy of thyroid nodule malignancy detection, thereby contributing to advancements in personalized and precision medicine in the field of thyroid cancer research. © The Author(s) 2025.